Articles from Cytotrait

Cytotrait, a biotechnology company harnessing a unique organelle editing approach to develop new crop traits for food and agriculture, today announced the appointment of Dr Ian Jepson as a Non-Executive Director of the Company. With more than 36 years’ experience in global leadership and commercial growth, Dr Jepson will support the Company’s ongoing strategy to develop its proprietary Mutant Organelle Selection System (MOSS) platform, initiate new trait development programmes in major global crop species and establish industry partnerships to commercialise the Company’s products.